Showing results (151-160 of 263) with videos related to

Sort By:
Pageof 27
Experimental Hematology|June 19, 2012
Impact of anti-HLA antibodies on allogeneic hematopoietic stem cell transplantation outcomes after reduced-intensity conditioning regimensMarie Detrait, Valérie Dubois, Mohamad Sobh, et al.
Cancer|August 22, 2019
Transplantation in adults with relapsed/refractory acute lymphoblastic leukemia who are treated with blinatumomab from a phase 3 studyElias J Jabbour, Nicola Gökbuget, Hagop M Kantarjian, et al.
Haematologica|March 15, 2006
Long-term follow-up of autologous stem cell transplantation after intensive chemotherapy in patients with myelodysplastic syndrome or secondary acute myeloid leukemiaSophie Ducastelle, Lionel Adès, Claude Gardin, et al.
Leukemia & Lymphoma|December 8, 2011
Infectious complications in adult acute myeloid leukemia: analysis of the Acute Leukemia French Association-9802 prospective multicenter clinical trialGiovanna Cannas, Cécile Pautas, Emmanuel Raffoux, et al.
Experimental Hematology|November 9, 2010
Telomere deregulations possess cytogenetic, phenotype, and prognostic specificities in acute leukemiasValérie Capraro, Linda Zane, Delphine Poncet, et al.
Haematologica|February 24, 2018
Clinical relevance of IDH1/2 mutant allele burden during follow-up in acute myeloid leukemia. A study by the French ALFA groupYann Ferret, Nicolas Boissel, Nathalie Helevaut, et al.
Cancers|April 25, 2019
Prognostic Value of Genetic Alterations in Elderly Patients with Acute Myeloid Leukemia: A Single Institution ExperienceMaël Heiblig, Hélène Labussière-Wallet, Franck Emmanuel Nicolini, et al.
Leukemia & Lymphoma|November 6, 2020
Blinatumomab + ponatinib for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia in adultsMarie-Anne Couturier, Xavier Thomas, Emmanuel Raffoux, et al.
Neoplasia (New York, N.Y.)|February 25, 2014
Chromatin redistribution of the DEK oncoprotein represses hTERT transcription in leukemiasMaroun Karam, Morgan Thenoz, Valérie Capraro, et al.
Blood|August 28, 2009
Phase 3 randomized, placebo-controlled, double-blind study of high-dose continuous infusion cytarabine alone or with laromustine (VNP40101M) in patients with acute myeloid leukemia in first relapseFrancis Giles, Norbert Vey, Daniel DeAngelo, et al.
Pageof 27